Posted by Michael Wonder on 15 Aug 2023
PHARMAC indicates interest to fund more oestradiol treatments to relieve supply issue
15 August 2023 - PHARMAC is planning to issue a competitive process for supply of oestradiol transdermal products in New Zealand.
“Today we have issued a Future Procurement Opportunity for oestradiol transdermal products,” says PHARMAC’s Chief Medical Officer Dr David Hughes. “This is an early stage in government procurement processes which signals to suppliers that we are getting closer to considering funding more products. It gives time to the suppliers to prepare their pricing proposals.”
